Lopinavir/ritonavir for treatment of non-hospitalized patients with COVID-19: a randomized clinical trial

OBJECTIVES: Effective and widely available therapies are still needed for outpatients with COVID-19. We aimed to evaluate the efficacy and safety of lopinavir/ritonavir (LPV/r) for early treatment of non-hospitalized individuals diagnosed with COVID-19. METHODS: This randomized, placebo (Plb)-contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaizer, Alexander M., Shapiro, Nathan I., Wild, Jessica, Brown, Samuel M., Cwik, B. Jessica, Hart, Kimberly W., Jones, Alan E., Pulia, Michael S., Self, Wesley H., Smith, Clay, Smith, Stephanie A., Ng, Patrick C., Thompson, B. Taylor, Rice, Todd W., Lindsell, Christopher J., Ginde, Adit A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792182/
https://www.ncbi.nlm.nih.gov/pubmed/36581186
http://dx.doi.org/10.1016/j.ijid.2022.12.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792182/
https://www.ncbi.nlm.nih.gov/pubmed/36581186
http://dx.doi.org/10.1016/j.ijid.2022.12.028

Ejemplares similares